AMBITION DX HOLDINGS Co., Ltd.
(Correction) Notice of recording of extraordinary losses and correction related to the difference between the full-year consolidated earnings forecast for the six-month period ending June 2026 and the actual results, and other corrections
Decided to recognize new extraordinary losses. For the restructuring of the DR AFT Lifeline business, will recognize goodwill impairment and write off deferred tax assets as part of accounting treatment. FY2027 consolidated earnings forecast remains unchanged, but YoY will be revised due to corrections in 2026 results.
Key Figures
- Extraordinary losses (impairment losses): 238,340 thousand yen
- Write-off of recoverability of deferred tax assets: 28,517 thousand yen
- 2027 year-end forecast: Sales 60,000 million yen / Operating income 5,100 million yen / Ordinary income 4,200 million yen / Net income attributable to owners of parent 2,600 million yen
AI要約
Recording of extraordinary losses and corrections
The company reevaluated the judgment based on the six-month period ending June 2026 financial results summary and decided to record extraordinary losses associated with the restructuring of the consolidated subsidiary DR AFT. The full amount of goodwill has been recognized as an impairment loss, and the recoverability of deferred tax assets has been reassessed and written off. These changes will affect key indicators in the consolidated income statement such as net income and comprehensive income, but there is no impact on cash flow.
Outlook and impact of corrections
The consolidated earnings forecast for the year ending June 2027 remains unchanged at this stage. Revenue 60,000 million yen, operating income 5,100 million yen, ordinary income 4,200 million yen, and net income attributable to owners of parent 2,600 million yen are unchanged. However, due to the revisions to 2026 actual results, the year-on-year growth rate has been revised, and net income attributable to owners of parent is expected to rise by 27.1%.
Ambition DX Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
